Related Experiment Video
Updated: Aug 5, 2025

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Knockdown of PAC1 improved inflammatory pain in mice by regulating the RAGE/TLR4/NF-κB signaling pathway
1Department of Vascular Intervention, Ninth Hospital of Xi'an, Xi'an, Shaanxi 710054, China.
Abstract:
The development of inflammatory pain seriously affects the activities and general functions of patients in daily life. At present, the research on the mechanism of pain relief is still insufficient. This study aimed to investigate the influence of PAC1 on the progression of inflammatory pain and its molecular mechanism. Lipopolysaccharide (LPS) was used to induce BV2 microglia activation to establish an inflammation model, and CFA injection was used to establish a mouse inflammatory pain model. The results showed that PAC1 was highly expressed in BV2 microglia induced by LPS. Knockdown of PAC1 significantly reduced LPS-induced inflammation and apoptosis in BV2 cells, and RAGE/TLR4/NF-κB signaling pathway was involved in the regulation of BV2 cells by PAC1. What's more, knockdown of PAC1 alleviated CFA-induced mechanical allodynia and thermal hyperalgesia in mice, as well as reduced the development of inflammatory pain to a certain extent. Therefore, Knockdown of PAC1 relieved inflammatory pain in mice by inhibiting the RAGE/TLR4/NF-κB signaling pathway. Targeting PAC1 may be a new direction for the treatment of inflammatory pain.
Insights
Targeting PAC1, a protein highly expressed in microglia during inflammation, can alleviate inflammatory pain. Reducing PAC1 levels inhibits key inflammatory pathways, offering a potential new treatment strategy for pain relief.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Inflammatory pain significantly impairs daily life, yet mechanisms for pain relief remain underexplored.
- Understanding the molecular underpinnings of inflammatory pain is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of PAC1 in the progression of inflammatory pain.
- To elucidate the molecular mechanisms by which PAC1 influences inflammatory pain.
Main Methods:
- Established an inflammation model using lipopolysaccharide (LPS) to activate BV2 microglia.
- Induced inflammatory pain in mice using Complete Freund's Adjuvant (CFA) injection.
- Assessed the effects of PAC1 knockdown on inflammatory responses, apoptosis, and pain behaviors in vitro and in vivo.
Main Results:
- PAC1 expression was elevated in LPS-induced BV2 microglia.
- Knockdown of PAC1 reduced LPS-induced inflammation and apoptosis in BV2 cells.
- PAC1 knockdown alleviated CFA-induced mechanical allodynia and thermal hyperalgesia in mice.
- PAC1 regulates BV2 cells via the RAGE/TLR4/NF-κB signaling pathway.
Conclusions:
- Knockdown of PAC1 alleviates inflammatory pain in mice by inhibiting the RAGE/TLR4/NF-κB signaling pathway.
- Targeting PAC1 presents a promising new therapeutic strategy for managing inflammatory pain.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Nociception
Analgesia and Pain Management
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

